These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 10456942

  • 1. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.
    McCool TL, Harding CV, Greenspan NS, Schreiber JR.
    Infect Immun; 1999 Sep; 67(9):4862-9. PubMed ID: 10456942
    [Abstract] [Full Text] [Related]

  • 2. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV.
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [Abstract] [Full Text] [Related]

  • 3. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein.
    Kamboj KK, Kirchner HL, Kimmel R, Greenspan NS, Schreiber JR.
    J Infect Dis; 2003 May 15; 187(10):1629-38. PubMed ID: 12721943
    [Abstract] [Full Text] [Related]

  • 4. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
    Mawas F, Feavers IM, Corbel MJ.
    Vaccine; 2000 Dec 08; 19(9-10):1159-66. PubMed ID: 11137252
    [Abstract] [Full Text] [Related]

  • 5. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA, Converso TR, Gonçalves VM, Leite LCC, Tanizaki MM, Barazzone GC.
    Clin Vaccine Immunol; 2017 Aug 08; 24(8):. PubMed ID: 28637805
    [Abstract] [Full Text] [Related]

  • 6. Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
    de Velasco EA, Merkus D, Anderton S, Verheul AF, Lizzio EF, Van der Zee R, Van Eden W, Hoffman T, Verhoef J, Snippe H.
    Infect Immun; 1995 Mar 08; 63(3):961-8. PubMed ID: 7532630
    [Abstract] [Full Text] [Related]

  • 7. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 08; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Caro-Aguilar I, Indrawati L, Kaufhold RM, Gaunt C, Zhang Y, Nawrocki DK, Giovarelli C, Winters MA, Smith WJ, Heinrichs J, Skinner JM.
    Vaccine; 2017 Feb 07; 35(6):865-872. PubMed ID: 28087148
    [Abstract] [Full Text] [Related]

  • 9. Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface.
    Lai Z, Schreiber JR.
    Vaccine; 2009 May 21; 27(24):3137-44. PubMed ID: 19446183
    [Abstract] [Full Text] [Related]

  • 10. Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier.
    Deauvieau F, Dussurgey S, Rossignol D, de Montfort A, Burdin N, Guy B.
    Vaccine; 2009 Dec 11; 28(2):576-82. PubMed ID: 19878751
    [Abstract] [Full Text] [Related]

  • 11. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M, Eskola J, Ahman H, Käyhty H.
    J Infect Dis; 1998 Jun 11; 177(6):1614-21. PubMed ID: 9607841
    [Abstract] [Full Text] [Related]

  • 12. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
    Alexander J, del Guercio MF, Frame B, Maewal A, Sette A, Nahm MH, Newman MJ.
    Vaccine; 2004 Jun 23; 22(19):2362-7. PubMed ID: 15193395
    [Abstract] [Full Text] [Related]

  • 13. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Madore D.
    Pediatr Infect Dis J; 1996 May 23; 15(5):425-30. PubMed ID: 8724065
    [Abstract] [Full Text] [Related]

  • 14. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.
    Michon F, Fusco PC, Minetti CA, Laude-Sharp M, Uitz C, Huang CH, D'Ambra AJ, Moore S, Remeta DP, Heron I, Blake MS.
    Vaccine; 1998 Nov 23; 16(18):1732-41. PubMed ID: 9778749
    [Abstract] [Full Text] [Related]

  • 15. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
    Kamboj KK, King CL, Greenspan NS, Kirchner HL, Schreiber JR.
    J Infect Dis; 2001 Oct 01; 184(7):931-5. PubMed ID: 11528593
    [Abstract] [Full Text] [Related]

  • 16. Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C.
    Sikkema DJ, Ziembiec NA, Jones TR, Hildreth SW, Madore DV, Quataert SA.
    Clin Diagn Lab Immunol; 2005 Jan 01; 12(1):218-23. PubMed ID: 15643011
    [Abstract] [Full Text] [Related]

  • 17. Genetic variation influences the B-cell response to immunization with a pneumococcal polysaccharide conjugate vaccine.
    McCool TL, Schreiber JR, Greenspan NS.
    Infect Immun; 2003 Sep 01; 71(9):5402-6. PubMed ID: 12933893
    [Abstract] [Full Text] [Related]

  • 18. Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies.
    Pawlowski A, Källenius G, Svenson SB.
    Vaccine; 2000 Mar 17; 18(18):1873-85. PubMed ID: 10699336
    [Abstract] [Full Text] [Related]

  • 19. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
    Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC, Sacerdote DM, Bradford N, Moore C.
    Pediatr Infect Dis J; 1998 Aug 17; 17(8):685-91. PubMed ID: 9726341
    [Abstract] [Full Text] [Related]

  • 20. Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccines.
    Bolgiano B, Mawas F, Yost SE, Crane DT, Lemercinier X, Corbel MJ.
    Vaccine; 2001 Apr 30; 19(23-24):3189-200. PubMed ID: 11312015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.